Literature DB >> 14648718

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.

Susan Neuhausen1, Alison Dunning, Linda Steele, Kazuko Yakumo, Michael Hoffman, Csilla Szabo, Louise Tee, Caroline Baines, Paul Pharoah, David Goldgar, Doug Easton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14648718     DOI: 10.1002/ijc.11385

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  13 in total

1.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Authors: 
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

Review 2.  The Epidemiology of Male Breast Cancer.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.075

3.  Strictly defined familial male breast cancer.

Authors:  Uwe Güth; Dieter Müller; Dorothy Jane Huang; Ellen Obermann; Hansjakob Müller
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

4.  Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mingming Liang; Yun Zhang; Chenyu Sun; Feras Kamel Rizeq; Min Min; Tingting Shi; Yehuan Sun
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

5.  A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers.

Authors:  Deborah Thompson; Sheila Seal; Mieke Schutte; Lesley McGuffog; Rita Barfoot; Anthony Renwick; Rosalind Eeles; Nayanta Sodha; Richard Houlston; Susan Shanley; Jan Klijn; Marijke Wasielewski; Jenny Chang-Claude; P Andrew Futreal; Barbara L Weber; Katherine L Nathanson; Michael Stratton; Hanne Meijers-Heijboer; Nazneen Rahman; Douglas F Easton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12       Impact factor: 4.254

6.  Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women.

Authors:  Danielle M Friedrichsen; Kathleen E Malone; David R Doody; Janet R Daling; Elaine A Ostrander
Journal:  Breast Cancer Res       Date:  2004-09-22       Impact factor: 6.466

7.  Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals.

Authors:  C R Jekimovs; X Chen; J Arnold; M Gatei; D J Richard; A B Spurdle; K K Khanna; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

8.  Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.

Authors:  Gregory S Calip; John Kidd; Ryan Bernhisel; Hannah C Cox; Jennifer Saam; Garth H Rauscher; Johnathan M Lancaster; Kent F Hoskins
Journal:  Breast Cancer Res Treat       Date:  2020-09-11       Impact factor: 4.872

9.  Inherited and acquired alterations in development of breast cancer.

Authors:  Piera Rizzolo; Valentina Silvestri; Mario Falchetti; Laura Ottini
Journal:  Appl Clin Genet       Date:  2011-11-14

Review 10.  Optimal delivery of male breast cancer follow-up care: improving outcomes.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.